Friday, October 28, 2016 2:59:50 PM
October 27, 2016
EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter earnings of $37.6 million.
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of 50 cents. Earnings, adjusted for restructuring costs and pretax expenses, were 53 cents per share.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 52 cents per share.
The medical device company posted revenue of $376.7 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $372.7 million.
West Pharmaceutical shares have climbed 17 percent since the beginning of the year. The stock has climbed 23 percent in the last 12 months.
Get your swing trade ideas at http://investorshub.advfn.com/boards/board.aspx?board_id=11403
Recent WST News
- West to Participate in Upcoming Investor Conference • PR Newswire (US) • 04/30/2024 10:00:00 AM
- West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend • PR Newswire (US) • 04/25/2024 10:00:00 AM
- West to Host First-Quarter 2024 Conference Call • PR Newswire (US) • 04/11/2024 10:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/01/2024 09:24:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 06:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:35:17 PM
- West to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/28/2024 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 09:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 04:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:50:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:47:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:40:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:29:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:16:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:13:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:01:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 09:44:29 PM
- West Announces Second-Quarter 2024 Dividend • PR Newswire (US) • 02/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:51:00 PM
- West Announces Fourth-Quarter and Full-Year 2023 Results • PR Newswire (US) • 02/15/2024 11:00:00 AM
- West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity • PR Newswire (US) • 02/07/2024 01:00:00 PM
- West to Host Fourth-Quarter and Full-Year 2023 Conference Call • PR Newswire (US) • 02/01/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 10:23:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM